SCHEMBL23083345

SCHEMBL23083345

CC(C)(C)C1CNCC12CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18624719 0.91 — —
SCHEMBL18642967 0.89 — —
SCHEMBL27114615 0.82 GRIN2D (0.33) —
SCHEMBL15447902 0.79 — —
SCHEMBL22743630 0.71 — —
SCHEMBL18642975 0.71 SOS1 (0.31) —
SCHEMBL22743841 0.71 GBA1 (0.31) —
SCHEMBL18477434 0.71 — —
SCHEMBL16653850 0.71 — —
SCHEMBL17721097 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303563-A1 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER 2023-09-28 — — US disclosed
US-20220242859-A1 INHIBITORS OF SARM1 DISARM THERAPEUTICS, INC. 2022-08-04 — — US disclosed
WO-2021043209-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 广东东阳光药业有限公司 2021-03-11 — — WO disclosed
Send feedback